ROSEN Law Firm Encourages REGENXBIO Investors to Seek Counsel

The firm is investigating potential securities claims on behalf of REGENXBIO shareholders.

Mar. 14, 2026 at 7:50pm

Got story updates? Submit your updates here. ›

ROSEN, a global investor rights law firm, is encouraging investors in REGENXBIO, Inc. to seek legal counsel regarding potential securities claims against the company. The firm is investigating issues related to REGENXBIO's business and operations.

Why it matters

REGENXBIO is a biotechnology company focused on gene therapy products, and any potential legal issues or claims against the company could impact investor confidence and the stock price.

The details

ROSEN Law Firm is investigating potential securities claims on behalf of REGENXBIO shareholders. The investigation is focused on issues related to the company's business and operations, though specific details have not been disclosed.

  • The investigation was announced on March 14, 2026.

The players

ROSEN Law Firm

A global investor rights law firm that specializes in representing investors in securities class actions and shareholder derivative litigation.

REGENXBIO, Inc.

A biotechnology company focused on developing gene therapy products to treat rare genetic diseases.

Got photos? Submit your photos here. ›

What’s next

The ROSEN Law Firm is encouraging REGENXBIO investors to contact the firm to discuss their legal options.

The takeaway

Potential legal issues or claims against REGENXBIO could impact investor confidence in the company, highlighting the importance for shareholders to seek counsel and understand their rights.